Antidepressants Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Antidepressants stocks.

Antidepressants Stocks Recent News

Date Stock Title
May 10 AXSM Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
May 9 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 8 NRXP NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
May 8 NRXP NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
May 8 AXSM Axsome Therapeutics to Present at Upcoming Investor Conferences
May 7 NRXP NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
May 7 AXSM Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
May 7 AXSM Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
May 7 VTGN Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 7 SAGE Sage Therapeutics to Participate in Upcoming May Investor Conferences
May 7 AXSM Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
May 7 AXSM Q1 2024 Axsome Therapeutics Inc Earnings Call
May 6 AXSM Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
May 6 NERV Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
May 6 AXSM Axsome Therapeutics, Inc. (AXSM) Q1 2024 Earnings Call Transcript
May 6 NRXP NRx Pharmaceuticals climbs on positive results from its bipolar depression treatment trial
May 6 NRXP NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
May 6 AXSM Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
May 6 AXSM Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Antidepressants

Antidepressants are drugs used for the treatment of major depressive disorder and of other conditions, including some anxiety disorders, some chronic pain conditions, and to help manage some addictions.Typical side-effects of antidepressants include dry mouth, weight gain, and lack of sex drive. Most types of antidepressants are typically safe to take, but may cause increased thoughts of suicide when taken by children, adolescents, and young adults. A discontinuation syndrome can occur after stopping any antidepressant. The risk is greater among those who have taken the medication for longer and when the medication in question has a short half-life. The problem usually begins within three days and may last for several months. Methods of prevention include gradually decreasing the dose among those who wish to stop, though it is possible for symptoms to occur with tapering.The most important classes of antidepressants are:
selective serotonin reuptake inhibitors (SSRIs)
serotonin norepinephrine reuptake inhibitors (SNRIs)
tricyclic antidepressants (TCAs)
monoamine oxidase inhibitors (MAOIs)
reversible inhibitors of monoamine oxidase A (RIMAs)
tetracyclic antidepressants (TeCAs)
noradrenergic and specific serotonergic antidepressant (NaSSAs)The plant St John's wort is also used in the treatment of depression.Bupropion, a NDRI, also operates as antidepressant.One theory regarding the cause of depression is that it is characterized by an overactive hypothalamic–pituitary–adrenal axis (HPA axis) that resembles the neuro-endocrine response to stress. HPA-axis abnormalities participate in the development of depressive symptoms, and antidepressants may serve to regulate HPA-axis function.The medical community has long debated the effectiveness of antidepressants, concentrating on whether one can attribute observed results in patients to the placebo effect.

Browse All Tags